vs

Side-by-side financial comparison of Bausch & Lomb Corp (BLCO) and Camping World Holdings, Inc. (CWH). Click either name above to swap in a different company.

Bausch & Lomb Corp is the larger business by last-quarter revenue ($1.4B vs $1.2B, roughly 1.2× Camping World Holdings, Inc.). Bausch & Lomb Corp runs the higher net margin — -4.1% vs -9.3%, a 5.2% gap on every dollar of revenue. On growth, Bausch & Lomb Corp posted the faster year-over-year revenue change (9.8% vs -2.6%). Over the past eight quarters, Bausch & Lomb Corp's revenue compounded faster (13.1% CAGR vs -7.2%).

Bausch & Lomb is an American-Canadian eye health products company based in Vaughan, Ontario, Canada. It is one of the world's largest suppliers of contact lenses, lens care products, pharmaceuticals, intraocular lenses, and other eye surgery products. The company was founded in Rochester, New York, in 1853 by optician John Bausch and cabinet maker turned financial backer Henry Lomb. Until its sale in 2013, Bausch + Lomb was one of the oldest continually operating companies in the United States.

Camping World Holdings, Inc. is an American corporation specializing in selling recreational vehicles (RVs), recreational vehicle parts, and recreational vehicle service. They also sell supplies for camping. The company has its headquarters in Lincolnshire, Illinois. In October 2016 it became a publicly traded company when it raised $251 million in an IPO. Camping World has 202 locations. In addition to its RV dealerships and accessories stores, the company sells goods through phone order and...

BLCO vs CWH — Head-to-Head

Bigger by revenue
BLCO
BLCO
1.2× larger
BLCO
$1.4B
$1.2B
CWH
Growing faster (revenue YoY)
BLCO
BLCO
+12.3% gap
BLCO
9.8%
-2.6%
CWH
Higher net margin
BLCO
BLCO
5.2% more per $
BLCO
-4.1%
-9.3%
CWH
Faster 2-yr revenue CAGR
BLCO
BLCO
Annualised
BLCO
13.1%
-7.2%
CWH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BLCO
BLCO
CWH
CWH
Revenue
$1.4B
$1.2B
Net Profit
$-58.0M
$-109.1M
Gross Margin
28.8%
Operating Margin
8.0%
-4.3%
Net Margin
-4.1%
-9.3%
Revenue YoY
9.8%
-2.6%
Net Profit YoY
-1833.3%
-83.3%
EPS (diluted)
$-0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BLCO
BLCO
CWH
CWH
Q4 25
$1.4B
$1.2B
Q3 25
$1.3B
$1.8B
Q2 25
$1.3B
$2.0B
Q1 25
$1.1B
$1.4B
Q4 24
$1.3B
$1.2B
Q3 24
$1.2B
$1.7B
Q2 24
$1.2B
$1.8B
Q1 24
$1.1B
$1.4B
Net Profit
BLCO
BLCO
CWH
CWH
Q4 25
$-58.0M
$-109.1M
Q3 25
$-28.0M
$-40.4M
Q2 25
$-62.0M
$30.2M
Q1 25
$-212.0M
$-12.3M
Q4 24
$-3.0M
$-59.5M
Q3 24
$4.0M
$5.5M
Q2 24
$-151.0M
$9.8M
Q1 24
$-167.0M
$-22.3M
Gross Margin
BLCO
BLCO
CWH
CWH
Q4 25
28.8%
Q3 25
28.6%
Q2 25
30.0%
Q1 25
30.4%
Q4 24
31.3%
Q3 24
28.9%
Q2 24
30.3%
Q1 24
29.5%
Operating Margin
BLCO
BLCO
CWH
CWH
Q4 25
8.0%
-4.3%
Q3 25
7.4%
4.4%
Q2 25
-0.9%
6.6%
Q1 25
-7.3%
1.5%
Q4 24
6.8%
-1.3%
Q3 24
3.6%
3.7%
Q2 24
2.1%
5.3%
Q1 24
0.5%
0.3%
Net Margin
BLCO
BLCO
CWH
CWH
Q4 25
-4.1%
-9.3%
Q3 25
-2.2%
-2.2%
Q2 25
-4.9%
1.5%
Q1 25
-18.6%
-0.9%
Q4 24
-0.2%
-4.9%
Q3 24
0.3%
0.3%
Q2 24
-12.4%
0.5%
Q1 24
-15.2%
-1.6%
EPS (diluted)
BLCO
BLCO
CWH
CWH
Q4 25
$-0.16
Q3 25
$-0.08
Q2 25
$-0.18
Q1 25
$-0.60
Q4 24
$-0.00
Q3 24
$0.01
Q2 24
$-0.43
Q1 24
$-0.48

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BLCO
BLCO
CWH
CWH
Cash + ST InvestmentsLiquidity on hand
$383.0M
$215.0M
Total DebtLower is stronger
$5.0B
$1.5B
Stockholders' EquityBook value
$6.4B
$228.6M
Total Assets
$14.0B
$5.0B
Debt / EquityLower = less leverage
0.78×
6.44×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BLCO
BLCO
CWH
CWH
Q4 25
$383.0M
$215.0M
Q3 25
$310.0M
$230.5M
Q2 25
$266.0M
$118.1M
Q1 25
$202.0M
$20.9M
Q4 24
$305.0M
$208.4M
Q3 24
$329.0M
$28.4M
Q2 24
$285.0M
$23.7M
Q1 24
$315.0M
$29.7M
Total Debt
BLCO
BLCO
CWH
CWH
Q4 25
$5.0B
$1.5B
Q3 25
$5.0B
$1.5B
Q2 25
$5.0B
$1.5B
Q1 25
$4.8B
$1.5B
Q4 24
$4.8B
$1.5B
Q3 24
$4.6B
$1.5B
Q2 24
$4.6B
$1.5B
Q1 24
$4.6B
$1.6B
Stockholders' Equity
BLCO
BLCO
CWH
CWH
Q4 25
$6.4B
$228.6M
Q3 25
$6.4B
$296.2M
Q2 25
$6.4B
$340.5M
Q1 25
$6.4B
$310.5M
Q4 24
$6.5B
$326.6M
Q3 24
$6.6B
$151.6M
Q2 24
$6.5B
$149.7M
Q1 24
$6.7B
$142.8M
Total Assets
BLCO
BLCO
CWH
CWH
Q4 25
$14.0B
$5.0B
Q3 25
$13.8B
$5.0B
Q2 25
$13.8B
$5.2B
Q1 25
$13.4B
$5.1B
Q4 24
$13.5B
$4.9B
Q3 24
$13.5B
$4.7B
Q2 24
$13.3B
$5.0B
Q1 24
$13.3B
$5.1B
Debt / Equity
BLCO
BLCO
CWH
CWH
Q4 25
0.78×
6.44×
Q3 25
0.77×
5.00×
Q2 25
0.77×
4.42×
Q1 25
0.76×
4.87×
Q4 24
0.74×
4.64×
Q3 24
0.70×
10.09×
Q2 24
0.71×
10.28×
Q1 24
0.69×
11.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BLCO
BLCO
CWH
CWH
Operating Cash FlowLast quarter
$136.0M
$-227.2M
Free Cash FlowOCF − Capex
$60.0M
FCF MarginFCF / Revenue
4.3%
Capex IntensityCapex / Revenue
5.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-66.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BLCO
BLCO
CWH
CWH
Q4 25
$136.0M
$-227.2M
Q3 25
$137.0M
$139.8M
Q2 25
$35.0M
$187.9M
Q1 25
$-25.0M
$-232.5M
Q4 24
$22.0M
$-163.4M
Q3 24
$154.0M
$324.2M
Q2 24
$15.0M
$152.3M
Q1 24
$41.0M
$-68.0M
Free Cash Flow
BLCO
BLCO
CWH
CWH
Q4 25
$60.0M
Q3 25
$63.0M
Q2 25
$-54.0M
Q1 25
$-135.0M
Q4 24
$-70.0M
Q3 24
$94.0M
Q2 24
$-57.0M
Q1 24
$-26.0M
FCF Margin
BLCO
BLCO
CWH
CWH
Q4 25
4.3%
Q3 25
4.9%
Q2 25
-4.2%
Q1 25
-11.9%
Q4 24
-5.5%
Q3 24
7.9%
Q2 24
-4.7%
Q1 24
-2.4%
Capex Intensity
BLCO
BLCO
CWH
CWH
Q4 25
5.4%
Q3 25
5.8%
Q2 25
7.0%
Q1 25
9.7%
Q4 24
7.2%
Q3 24
5.0%
Q2 24
5.9%
Q1 24
6.1%
Cash Conversion
BLCO
BLCO
CWH
CWH
Q4 25
Q3 25
Q2 25
6.22×
Q1 25
Q4 24
Q3 24
38.50×
58.93×
Q2 24
15.59×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BLCO
BLCO

Overthe Counter Products$489.0M35%
Pharmaceuticals$378.0M27%
Other$263.0M19%
Surgical$249.0M18%
Brandedand Other Generic Products$14.0M1%
Other Revenues$3.0M0%
Pharmaceutical Products$2.0M0%

CWH
CWH

New Vehicles$457.8M39%
Used Vehicles$386.5M33%
Products Service And Other$160.5M14%
Finance And Insurance Net$111.4M9%
Good Sam Services And Plans$48.0M4%
Good Sam Club$10.5M1%

Related Comparisons